KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EBT (2016 - 2025)

Historic EBT for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $1.5 billion.

  • Amgen's EBT rose 9360.61% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.0 billion, marking a year-over-year increase of 9474.94%. This contributed to the annual value of $9.0 billion for FY2025, which is 9474.94% up from last year.
  • Amgen's EBT amounted to $1.5 billion in Q4 2025, which was up 9360.61% from $3.9 billion recorded in Q3 2025.
  • Over the past 5 years, Amgen's EBT peaked at $3.9 billion during Q3 2025, and registered a low of -$68.0 million during Q1 2024.
  • Moreover, its 5-year median value for EBT was $1.7 billion (2022), whereas its average is $1.8 billion.
  • Per our database at Business Quant, Amgen's EBT crashed by 10197.56% in 2024 and then skyrocketed by 300147.06% in 2025.
  • Amgen's EBT (Quarter) stood at $2.1 billion in 2021, then fell by 17.97% to $1.7 billion in 2022, then tumbled by 51.26% to $852.0 million in 2023, then dropped by 8.22% to $782.0 million in 2024, then surged by 93.61% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q4 2025, $3.9 billion for Q3 2025, and $1.6 billion during Q2 2025.